The balance sheet has deteriorated sharply, with total debt surging to $537.5M and cash reserves plummeting to $33.7M in 2026Q2, pushing the debt-to-equity ratio to 2.54 and indicating a critical need for additional capital.
Enovix Corporation (ENVX) balance sheet — 7-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Jan'23 | Jan'22 | Dec'20 | Dec'19 |
|---|
| Total Current Assets | 505.74M | 542.21M | 295.01M | 323.18M | 329.65M | 398.12M | 33.04M | 10.6M |
| Cash & Short-Term Investments | 475.78M | 512.04M | 272.87M | 306.81M | 322.85M | 385.29M | 29.14M | 10.23M |
| Cash Only | 33.74M | 106.01M | 272.87M | 233.12M | 322.85M | 385.29M | 29.14M | 10.23M |
| Short-Term Investments | 442.04M | 406.03M | 0 | 73.69M | 0 | 0 | 0 | 0 |
| Accounts Receivable | 3.1M | 8.43M | 4.57M | 2.42M | 170K | 300K | 0 | 0 |
| Days Sales Outstanding | 57.26 | 96.73 | 72.29 | 115.7 | 10 | - | - | - |
| Inventory | 17.52B | 13.62M | 7.66M | 8.74M | 634K | 0 | 0 | 0 |
| Days Inventory Outstanding | 36.08K | 83.62 | 111.36 | 50.57 | 9.96 | - | - | - |
| Other Current Assets | -17.49B | 8.12M | 9.9M | 5.2M | 5.99M | 4.25M | 2.96M | 75K |
| Total Non-Current Assets | 293.88M | 338.14M | 232.16M | 241.13M | 110.94M | 84.44M | 31.92M | 6.02M |
| Property, Plant & Equipment | 173.79B | 181.94M | 181.43M | 181.76M | 110M | 83.28M | 31.29M | 4.92M |
| Fixed Asset Turnover | 0.00x | 0.17x | 0.13x | 0.04x | 0.06x | - | - | - |
| Goodwill | 12.22B | 12.22M | 12.22M | 12.1M | 0 | 0 | 0 | 0 |
| Intangible Assets | 29.17B | 31.64M | 36.39M | 42.17M | 0 | 0 | 0 | 0 |
| Long-Term Investments | 322.8M | 106.81M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | -214.96B | 4.15M | 2.13M | 5.1M | 937K | 1.16M | 630K | 1.1M |
| Total Assets | 799.62M | 880.35M | 527.17M | 564.3M | 440.59M | 482.56M | 64.96M | 16.61M |
| Asset Turnover | 0.04x | 0.04x | 0.04x | 0.01x | 0.01x | - | - | - |
| Asset Growth % | 308.49% | 67% | -6.58% | 28.08% | -8.7% | 642.82% | 291.02% | - |
| Total Current Liabilities | 52.11M | 65.02M | 53.7M | 61.02M | 23.03M | 20.64M | 10.87M | 1.03M |
| Accounts Payable | 12.17M | 17.82M | 9.49M | 21.25M | 7.08M | 3.14M | 2.08M | 257K |
| Days Payables Outstanding | 136.19 | 109.42 | 137.93 | 123 | 111.15 | 583.41 | 225.27 | 582.64 |
| Short-Term Debt | 10.59M | 9.87M | 9.45M | 5.92M | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 3.73B | 5.01M | 3.65M | 6.71M | 50K | 5.58M | 5.41M | 0 |
| Other Current Liabilities | -3.68B | 26.1M | 11.26M | 13.17M | 8.81M | 4.81M | 1.38M | 95K |
| Current Ratio | 9.71x | 8.34x | 5.49x | 5.30x | 14.31x | 19.29x | 3.04x | 10.33x |
| Quick Ratio | -326.51x | 8.13x | 5.35x | 5.15x | 14.29x | 19.29x | 3.04x | 10.33x |
| Cash Conversion Cycle | 36.01K | 70.93 | 45.73 | 43.27 | -91.19 | - | - | - |
| Total Non-Current Liabilities | 535.52M | 541.32M | 224.06M | 242.18M | 61.13M | 135.81M | 17.88M | 11.88M |
| Long-Term Debt | 520.99M | 519.27M | 169.82M | 169.1M | 0 | 0 | 0 | 5.65M |
| Capital Lease Obligations | 39.46M | 11.24M | 13.29M | 15.59M | 8.23M | 9.07M | 0 | 0 |
| Deferred Tax Liabilities | 37.02M | 10.49M | 8.78M | 10.8M | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 13K | 14K | 28.39M | 42.91M | 49.17M | 124.45M | 17.8M | 6.23M |
| Total Liabilities | 587.63M | 606.34M | 277.77M | 303.2M | 84.16M | 156.45M | 28.75M | 12.91M |
| Total Debt | 537.48M | 540.38M | 192.56M | 190.61M | 8.23M | 9.07M | 0 | 5.65M |
| Net Debt | 503.74M | 434.37M | -80.3M | -42.51M | -314.62M | -376.22M | -29.14M | -4.58M |
| Debt / Equity | 2.54x | 1.97x | 0.77x | 0.73x | 0.02x | 0.03x | - | 1.52x |
| Debt / EBITDA | -3.81x | - | - | - | - | - | - | - |
| Net Debt / EBITDA | -3.57x | - | - | - | - | - | - | - |
| Interest Coverage | -4.39x | -6.31x | -31.99x | -47.20x | -9.87x | -672.12x | -219.91x | - |
| Total Equity | 211.99M | 274.01M | 249.4M | 261.1M | 356.43M | 326.12M | 36.22M | 3.71M |
| Equity Growth % | 89.05% | 9.87% | -4.48% | -26.74% | 9.29% | 800.48% | 876.7% | - |
| Book Value per Share | 0.97 | 1.32 | 1.42 | 1.65 | 2.31 | 2.78 | 0.25 | 0.06 |
| Total Shareholders' Equity | 209.94M | 271.21M | 246.74M | 258.15M | 356.43M | 326.12M | 36.22M | 3.71M |
| Common Stock | 23K | 22K | 19K | 17K | 15K | 15K | 10K | 59K |
| Retained Earnings | -1.06B | -977.83M | -821.09M | -598.85M | -384.77M | -333.15M | -207.28M | -167.63M |
| Treasury Stock | -58.38M | -58.38M | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -1.42M | -508K | -143K | -62K | 0 | 0 | 0 | 0 |
| Minority Interest | 2.04M | 2.8M | 2.66M | 2.96M | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying ENVX stock.
As of 2025, Enovix Corporation (ENVX) had total assets of $880.3M including $542.2M in current assets.
Enovix Corporation (ENVX) carries total debt of $540.4M, offset by $512.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Enovix Corporation (ENVX) has total shareholders' equity (book value) of $271.2M ($1.32 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Enovix Corporation (ENVX) reported a current ratio of 8.34x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Rapid cash depletion amid scaling
Metrics are mathematically derived from official filings.
Leverage Spikes as Cash Reserves Deplete
The balance sheet has deteriorated sharply over the last two quarters, with total debt surging to $537.5M and cash plummeting to $33.7M, as reported in the latest filings, indicating a significant shift in capital structure to fund the Malaysia facility ramp.
The D/E ratio has ballooned from 0.93 in 2025Q2 to 2.54 in 2026Q2, suggesting the company has moved from a relatively conservative position to one of high leverage to finance its manufacturing expansion. This rapid increase in debt, coupled with a steep decline in cash reserves, signals that the business is now heavily reliant on external financing to fund its operations and capital expenditures, which may constrain future strategic flexibility.
Leverage Surge Driven by Expansion Financing
Total debt has increased by approximately $345M since 2025Q2, reaching $537.5M in 2026Q2, which has pushed the D/E ratio to 2.54 and suggests the company is leveraging its balance sheet to fund the capital-intensive Malaysia facility.
The debt load appears to be a strategic necessity to finance the Gen2 Autoline and high-volume manufacturing transition, rather than a reflection of operational cash flow generation. The current ratio remains high at 9.71, but this is largely due to the composition of current assets; the underlying trend of rising debt against a shrinking cash position warrants close monitoring for refinancing risk and interest coverage as the company approaches commercial scale.
Cash Runway Narrows Dramatically
Cash reserves have fallen from $335.5M in 2025Q3 to just $33.7M in 2026Q2, a decline of over 90% in nine months, which, when viewed against the TTM operating loss, suggests a critically short runway before additional financing is required.
The current ratio of 9.71 is misleadingly strong, as it is inflated by non-cash assets and does not reflect the acute pressure on liquid funds. The rapid depletion of cash indicates that the company's operating burn and capital expenditure needs are consuming its reserves at an unsustainable rate, making the achievement of positive cash flow from the Malaysia ramp a critical near-term milestone.
Equity Eroded by Persistent Operating Losses
Accumulated retained losses have widened to -$1.1B as of 2026Q2, representing a significant drag on total equity and indicating that the company's growth has been entirely funded by debt and external capital rather than internal profit generation.
The negative retained earnings balance is a direct result of the company's pre-scale operating model, where substantial R&D and SG&A expenses have consistently outpaced minimal revenue. This structural deficit in equity quality means the company's net worth is heavily dependent on the future market value of its intellectual property and manufacturing assets, rather than a history of profitable operations.
Misleading Liquidity from Current Ratio Distortion
The headline current ratio of 9.71 in 2026Q2 appears robust but is likely distorted by the composition of current assets, as the sharp decline in cash suggests that a significant portion of current assets may be tied up in less liquid inventory or receivables.
Investors should scrutinize the working capital components, as the company's negative gross margins historically imply potential inventory obsolescence or write-down risk during the production ramp. The high current ratio may therefore provide a false sense of security, masking the true liquidity challenge posed by the need to convert inventory into cash to fund ongoing operations.